Skip to content

Development and Validation of a Therapeutic Decision Aid in Ectopic Pregnancy: GEUDECID Study

Development and Validation of a Therapeutic Decision Aid in Less Active Ectopic Pregnancy

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05745831
Acronym
GEUDECID
Enrollment
109
Registered
2023-02-27
Start date
2023-10-22
Completion date
2024-04-22
Last updated
2026-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

To Validate a Decision Aid for Ectopic Pregnancy

Keywords

decision aid, shared decision making, less active ectopic pregnancy, methotrexate, medical treatment, surgery

Brief summary

The aim's study is to validate a therapeutic aid in women with a less active ectopic pregnancy. A prospective recrutement of 100 women will be performed in 16 different hospitals in France. The decision aid will be used and a questionnaire about its usefulness, comprehension and satisfaction will be given to women and doctors.

Detailed description

In less active ectopic pregnancy, two treatments are possible: a medical treatment using methotrexate or a surgical management. A discret choice experiment study was performed to reveal women's preferences between these two options. In conclusion, calculated preferences are 47.5 and 52.5%, revealing a difficult choice for women. This study also lead to identify the main attributes important to make the choice. We were then able to create a therapeutic decision aid to help this shared decision. This aid needs to be validated, following steps for validation. This study is the last step in women in situation of less active ectopic pregnancy.

Interventions

OTHERTherapeutic decision tool

A therapeutic decision tool will be used and its usefulness, comprehension and satisfaction will be evaluated

Sponsors

Institut National de la Santé Et de la Recherche Médicale, France
Lead SponsorOTHER_GOV

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
OTHER
Masking
NONE

Intervention model description

Prospective mulicentric study

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 45 Years
Healthy volunteers
No

Inclusion criteria

* Women who speak and read french * Not opposed to participate to the research * With a tubal ectopic pregnancy visible at sonography * with an HCG rate under 10 000UI/ml

Exclusion criteria

* Cardiac activity present in the embryo * Hemoperitoin * Hemodynamic instability * Spontaneous pelvic pain * Contre indication to methotrexate * Protected adult patient

Design outcomes

Primary

MeasureTime frameDescription
Validate acceptability of the therapeutic decision tool in women managed for less active ectopic tubal pregnancy.One dayAcceptability will be evaluated using a score from the Traditional Decisional Conflict Scale (DCS) translated in french. Women will fill it after the choice of the treatment and the realisation of it.

Secondary

MeasureTime frameDescription
Validate acceptability of the therapeutic decision tool in doctors who managed women for less active ectopic tubal pregnancy.One dayThe same Traditional Decisional Conflict Scale (DCS) will be used in gynecologist who will managed the women
To evaluate satisfaction of women and of doctor in using the toolOne dayA specific questionnaire using Likert scale will be used

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Apr 30, 2026